Analysed VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) News Sources
Does Voyager Therapeutics’ (VYGR) Widening Annual Loss Redefine the Risk-Reward in Its Neurology Pipeline?
12-03-2026
yahoo.com
Voyager Therapeutics Conference: CEO Calls 2026 “Year of Tau,” Eyes BBB Capsid Clinic Debut
23-03-2026
marketbeat.com
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease
27-04-2026
yahoo.com
Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026
13-05-2026
yahoo.com
What is the current price of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)?
The current price of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) is $3.79.
VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) absolute price change since previous trading day?
The absolute price change of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) since the previous trading day is $-0.08.
VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) percentage price change since previous trading day?
The percentage price change of VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) since the previous trading day is -2.0672%.
What is the most recent average sentiment score for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)?
The most recent average sentiment score for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)?
The most recent sentiment for VOYAGER THERAPEUTICS INC (VYGR:NASDAQ) is .
SEC-8K** Filing Available For VOYAGER THERAPEUTICS INC (VYGR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.